Primary Mediastinal B-Cell Lymphoma

Bibliography

  1. Ahmed, Z., Afridi, S. S., Shahid, Z., Zamani, Z., Rehman, S., Aiman, W., Khan, M., Mir, M. A., Awan, F. T., Anwer, F., & Iftikhar, R. (2021). Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics. Clinical Lymphoma Myeloma and Leukemia, 21(11), e865–e875. https://doi.org/10.1016/j.clml.2021.06.012
  2. Al Shemmari, S., Sankaranarayanan, S. P., & Krishnan, Y. (2014). Primary mediastinal large B-cell lymphoma: Clinical features, prognostic factors and survival with RCHOP in Arab patients in the PET scan era. Lung India : Official Organ of Indian Chest Society, 31(3), 228–231. https://doi.org/10.4103/0970-2113.135760
  3. Aoki, T., Izutsu, K., Suzuki, R., Nakaseko, C., Arima, H., Shimada, K., Tomita, A., Sasaki, M., Takizawa, J., Mitani, K., Igarashi, T., Maeda, Y., Fukuhara, N., Ishida, F., Niitsu, N., Ohmachi, K., Takasaki, H., Nakamura, N., Kinoshita, T., ... Ogura, M. (2014). Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: A multicenter retrospective study in Japan. Haematologica, 99(12), 1817–1825. https://doi.org/10.3324/haematol.2014.111203
  4. Bea, S., Zettl, A., Wright, G., Salaverria, I., Jehn, P., Moreno, V., Burek, C., Ott, G., Puig, X., Yang, L., Lopez-Guillermo, A., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Gascoyne, R. D., Connors, J. M., Grogan, T. M., Braziel, R., ... Lymphoma/Leukemia Molecular Profiling Project. (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood, 106(9), 3183–3190. https://doi.org/10.1182/blood-2005-04-1399
  5. Belay, Y., Yirdaw, K., & Enawgaw, B. (2017). Tumor Lysis Syndrome in Patients with Hematological Malignancies. Journal of Oncology, 2017, 9684909. https://doi.org/10.1155/2017/9684909
  6. Bhatt, V. R., Mourya, R., Shrestha, R., & Armitage, J. O. (2015). Primary mediastinal large B-cell lymphoma. Cancer Treatment Reviews, 41(6), 476–485. https://doi.org/10.1016/j.ctrv.2015.04.006
  7. Bishop, P. C., Wilson, W. H., Pearson, D., Janik, J., Jaffe, E. S., & Elwood, P. C. (1999). CNS involvement in primary mediastinal large B-cell lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17(8), 2479–2485. https://doi.org/10.1200/JCO.1999.17.8.2479
  8. Camus, V., Drieux, F., & Jardin, F. (2022). State of the art in the diagnosis, biology and treatment of primary mediastinal B-cell lymphoma: A review. Annals of Lymphoma, 6(0), Article 0. https://doi.org/10.21037/aol-22-13
  9. Cazals-Hatem, D., Lepage, E., Brice, P., Ferrant, A., d'Agay, M. F., Baumelou, E., Briere, J., Blanc, M., Gaulard, P., Biron, P., Schlaifer, D., Diebold, J., & Audouin, J. (1996). Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. The American Journal of Surgical Pathology, 20(7), 877–888. https://doi.org/10.1097/00000478-199607000-00012
  10. Chen, H., Pan, T., He, Y., Zeng, R., Li, Y., Yi, L., Zang, H., Chen, S., Duan, Q., Xiao, L., & Zhou, H. (2021). Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. Frontiers in Oncology, 11. https://www.frontiersin.org/articles/10.3389/fonc.2021.654854
  11. Cwynarski, K., Marzolini, M. A. V., Barrington, S. F., Follows, G., Illidge, T., Stern, S., Davies, A., & Guidelines, the B. S. for H. (2019). The management of primary mediastinal B-cell lymphoma: A British Society for Haematology Good Practice Paper. British Journal of Haematology, 185(3), 402–409. https://doi.org/10.1111/bjh.15731
  12. Dunleavy, K., Pittaluga, S., Maeda, L. S., Advani, R., Chen, C. C., Hessler, J., Steinberg, S. M., Grant, C., Wright, G., Varma, G., Staudt, L. M., Jaffe, E. S., & Wilson, W. H. (2013). Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma. New England Journal of Medicine, 368(15), 1408–1416. https://doi.org/10.1056/NEJMoa1214561
  13. Hayden, A. R., Tonseth, P., Lee, D. G., Villa, D., Gerrie, A. S., Scott, D. W., Freeman, C. L., Slack, G. W., Farinha, P., Skinnider, B., Yenson, P. R., Benard, F., Lo, A., Pickles, T., Wilson, D., Connors, J. M., Sehn, L. H., & Savage, K. J. (2020). Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: Impact of a PET-adapted approach. Blood, 136(24), 2803–2811. https://doi.org/10.1182/blood.2019004296
  14. Jacobson, J. O., Aisenberg, A. C., Lamarre, L., Willett, C. G., Linggood, R. M., Miketic, L. M., & Harris, N. L. (1988). Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer, 62(9), 1893–1898. https://doi.org/10.1002/1097-0142(19881101)62:9<1893::aid-cncr2820620904>3.0.co;2-x
  15. Lees, C., Keane, C., Gandhi, M. K., & Gunawardana, J. (2019). Biology and therapy of primary mediastinal B-cell lymphoma: Current status and future directions. British Journal of Haematology, 185(1), 25–41. https://doi.org/10.1111/bjh.15778
  16. Lekovic, D., Miljic, P., & Mihaljevic, B. (2010). Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. Thrombosis Research, 126(6), 477–480. https://doi.org/10.1016/j.thromres.2010.08.017
  17. Martelli, M., Ferreri, A., Di Rocco, A., Ansuinelli, M., & Johnson, P. W. M. (2017). Primary mediastinal large B-cell lymphoma. Critical Reviews in Oncology/Hematology, 113, 318–327. https://doi.org/10.1016/j.critrevonc.2017.01.009
  18. National Cancer Institute (NCI). (2023). A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (Clinical Trial Registration NCT04759586). clinicaltrials.gov. https://clinicaltrials.gov/study/NCT04759586
  19. Neelapu, S. S., Jacobson, C. A., Ghobadi, A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., Deol, A., Reagan, P. M., Stiff, P., Flinn, I. W., Farooq, U., Goy, A. H., McSweeney, P. A., Munoz, J., Siddiqi, T., ... Locke, F. L. (2023). Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma. Blood, 141(19), 2307–2315. https://doi.org/10.1182/blood.2022018893
  20. Papageorgiou, S. G., Diamantopoulos, P., Levidou, G., Angelopoulou, M. K., Economopoulou, P., Efthimiou, A., Constantinou, N., Katsigiannis, A., Korkolopoulou, P., Pappa, V., Economopoulou, C., Georgiou, G., Dimou, M., Tsirigotis, P., Kyrtsonis, M.-C., Kotsianidis, I., Kalpadakis, C., Dimopoulos, M.-A., Beris, P., ... Vassilakopoulos, T. P. (2013). Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab. Hematological Oncology, 31(1), 10–17. https://doi.org/10.1002/hon.2012
  21. Purroy, N., Bergua, J., Gallur, L., Prieto, J., Lopez, L. A., Sancho, J. M., Garcia-Marco, J. A., Castellvi, J., Montes-Moreno, S., Batlle, A., de Villambrosia, S. G., Carnicero, F., Ferrando-Lamana, L., Piris, M. A., & Lopez, A. (2015). Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group. British Journal of Haematology, 169(2), 188–198. https://doi.org/10.1111/bjh.13273
  22. Savage, K. J., Al-Rajhi, N., Voss, N., Paltiel, C., Klasa, R., Gascoyne, R. D., & Connors, J. M. (2006). Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: The British Columbia experience. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 17(1), 123–130. https://doi.org/10.1093/annonc/mdj030
  23. Shah, N. N., Szabo, A., Huntington, S. F., Epperla, N., Reddy, N., Ganguly, S., Vose, J., Obiozor, C., Faruqi, F., Kovach, A. E., Costa, L. J., Xavier, A. C., Okal, R., Kanate, A. S., Ghosh, N., Kharfan-Dabaja, M. A., Strelec, L., Hamadani, M., Fenske, T. S., ... Svoboda, J. (2018). R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: A multi-centre analysis. British Journal of Haematology, 180(4), 534–544. https://doi.org/10.1111/bjh.15051
  24. Sheikh, Y., & Gaillard, F. (2010). Mediastinal lymphoma -- Large B-cell. In Radiopaedia.org. Radiopaedia.org. https://doi.org/10.53347/rID-8655
  25. Velasques, R. D., da Silva, W. F., Bellesso, M., Rocha, V., & Pereira, J. (2022). Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings. Journal of Oncology, 2022, 2099456. https://doi.org/10.1155/2022/2099456
  26. Yu, Y., Dong, X., Tu, M., & Wang, H. (2021). Primary mediastinal large B cell lymphoma. Thoracic Cancer, 12(21), 2831–2837. https://doi.org/10.1111/1759-7714.14155
  27. Yuan, J., Wright, G., Rosenwald, A., Steidl, C., Gascoyne, R. D., Connors, J. M., Mottok, A., Weisenburger, D. D., Greiner, T. C., Fu, K., Smith, L., Rimsza, L. M., Jaffe, E. S., Campo, E., Martinez, A., Delabie, J., Braziel, R. M., Cook, J. R., Ott, G., ... Project (LLMPP), F. the L. L. M. P. (2015). Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. The American Journal of Surgical Pathology, 39(10), 1322. https://doi.org/10.1097/PAS.0000000000000473
  28. Zinzani, P. L., Thieblemont, C., Melnichenko, V., Bouabdallah, K., Walewski, J., Majlis, A., Fogliatto, L., Garcia-Sancho, A. M., Christian, B., Gulbas, Z., Ozcan, M., Perini, G. F., Ghesquieres, H., Shipp, M. A., Thompson, S., Chakraborty, S., Marinello, P., & Armand, P. (2023). Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: Final analysis of KEYNOTE-170. Blood, 142(2), 141–145. https://doi.org/10.1182/blood.2022019340
  29. Zucca, E., Davies, A., Kryachok, I., Ciccone, G., Ceriani, L., Botto, B., Mikhaeel, N. G., Dabrowska-Iwanicka, A., Zhao, W., Inescu, C., Janikova, A., Fossa, A., Hodgson, D., Jerkeman, M., Balzarotti, M., Tucci, A., Ricardi, U., Barrington, S., Johnson, P. W. M., & Martelli, M. (2023). Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial. Journal of Clinical Oncology, 41(17_suppl), LBA7505–LBA7505. https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA7505
15 / 15